Tech Company Financing Transactions

Euthymics Bioscience Funding Round

On 6/30/2012, Euthymics Bioscience raised $3.7 million in funding from GBS Venture Partners, Hambrecht & Quist Capital Management and Novartis Venture Fund.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

1 Bdwy. 14th Floor
Cambridge, MA 02142
USA

Phone

(617) 682-3679

Website

www.euthymics.com

Email Address

[email protected]

Overview

Euthymics Bioscience, a neuroscience-focused biopharmaceutical company, develops medicines for central nervous system disorders.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Anthony McKinney

        

Chief Marketing Officer

Katherine Laessig

        

Browse more venture capital transactions:

Prev: 6/30/2012: SwiftStack venture capital transaction
Next: 6/30/2012: Jasper Design Automation venture capital transaction

Share this article

About Our Venture Capital Transactions Database

Our team works diligently to document funding rounds that are announced publicly. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary